https://www.cttpharmaceuticals.com/mindesta-announces-acquisition-of-ctt-pharmaceuticals-inc/2015-02-09T14:26:04-05:00https://www.cttpharmaceuticals.com/ctt-announces-the-appointment-of-steve-abboud-sme-medicinal-marijuana-to-advisory-board/2015-02-09T14:40:44-05:00https://www.cttpharmaceuticals.com/ctt-pharmaceutical-holdings-to-license-to-cannimed-ltd-novel-cannabis-orally-dissolvable-thin-film-odf-wafer-drug-delivery-technology-for-north-american-markets/2016-10-24T17:15:52-04:00https://www.cttpharmaceuticals.com/after-election-day-access-to-marijuana-likely-to-reach-all-time-high-across-nation/2016-10-28T09:42:49-04:00https://www.cttpharmaceuticals.com/marijuana-wins-big-on-election-night/2016-11-10T11:03:31-05:00https://www.cttpharmaceuticals.com/john-ivison-marijuana-report-to-urge-liberals-to-strike-at-the-black-market/2016-12-02T09:54:13-05:00https://www.cttpharmaceuticals.com/canopy-growths-430m-takeover-of-mettrum-would-be-biggest-ever-deal-in-global-marijuana-business/2016-12-08T09:42:10-05:00https://www.cttpharmaceuticals.com/cannimed-therapeutics-cronos-group-aphria-and-canopy-growth-shares-ignited-by-germanys-medical-marijuana-law/2017-01-31T08:47:21-05:00https://www.cttpharmaceuticals.com/ctt-pharmaceutical-holdings-and-cannimed-therapeutics-inc-complete-exclusive-canadian-licensing-agreement-for-cannabis-orally-dissolvable-thin-film-odf-wafer/2017-02-17T11:09:54-05:00https://www.cttpharmaceuticals.com/ctt-pharmaceutical-holdings-and-cannimed-therapeutics-inc-complete-exclusive-canadian-licensing-agreement-for-cannabis-orally-dissolvable-thin-film-odf-wafer-2/2017-02-17T11:21:36-05:00https://www.cttpharmaceuticals.com/independent-laboratory-analysis-confirms-cannimed-medical-cannabis-products-free-from-pesticides-fungicides-and-plant-growth-regulators/2017-02-22T09:13:48-05:00https://www.cttpharmaceuticals.com/liberals-to-announce-marijuana-will-be-legal-by-july-1-2018/2017-03-27T09:15:41-04:00https://www.cttpharmaceuticals.com/marijuana-etf-the-most-scrutinized-fund-that-weve-ever-launched-horizons-ceo-says/2017-03-30T10:08:12-04:00https://www.cttpharmaceuticals.com/meet-the-nff-new-group-to-lobby-trump-congress-on-cannabis/2017-04-03T10:11:00-04:00https://www.cttpharmaceuticals.com/aphria-takes-medical-marijuana-model-to-u-s-with-25-million-investment-in-florida/2017-04-06T10:01:33-04:00https://www.cttpharmaceuticals.com/marjiuana-bill-to-unleash-a-sea-change-in-public-policy-not-seen-since-the-1930s/2017-04-13T09:46:12-04:00https://www.cttpharmaceuticals.com/ctt-pharmaceuticals-holdings-inc-provides-corporate-update/2017-11-14T12:45:40-05:00https://www.cttpharmaceuticals.com/ctt-pharmaceutical-holdings-inc-ctth-announces-u-s-patent-for-therapeutic-composition-for-treating-psoriasis-with-cannabidiol-and-corticosteroids/2018-01-10T11:46:26-05:00https://www.cttpharmaceuticals.com/aurora-cannabis-and-cannimed-therapeutics-agree-to-terms-on-friendly-transaction/2018-11-06T11:36:00-05:00https://www.cttpharmaceuticals.com/aurora-cannabis-and-cannimed-therapeutics-file-offer-documents-for-previously-announced-friendly-acquisition/2018-11-06T11:35:41-05:00https://www.cttpharmaceuticals.com/aurora-announces-q2-fiscal-2018-results/2018-11-06T11:35:17-05:00https://www.cttpharmaceuticals.com/israel-scientific-study-cannabis-safe-and-effective-for-regular-use-in-the-elderly-can-decrease-the-use-of-other-prescription-medicines-including-opioids/2018-11-06T11:34:45-05:00https://www.cttpharmaceuticals.com/update-ctt-pharmaceutical-holdings-inc-ctth-announces-canadian-patent-for-orally-administrable-nanonized-cannabinoids-opioids-and-other-pharmaceutical-agents/2018-11-06T11:34:28-05:00https://www.cttpharmaceuticals.com/aurora-cannabis-announces-final-regulatory-approval-for-cannimed-therapeutics-acquisition/2018-11-06T11:34:11-05:00https://www.cttpharmaceuticals.com/aurora-acquires-cannimed-and-commences-integration/2018-11-06T11:33:43-05:00https://www.cttpharmaceuticals.com/medical-marijuana-may-reduce-opioid-use-a-little/2018-11-06T11:33:17-05:00https://www.cttpharmaceuticals.com/aurora-cannabis-gains-exclusive-license-to-novel-patented-sub-lingual-wafer-technology-from-ctt-pharmaceutical/2018-11-06T11:32:52-05:00https://www.cttpharmaceuticals.com/ctt-pharmaceutical-holdings-inc-provides-corporate-update-with-emphasis-on-patent-portfolio/2018-11-06T11:32:32-05:00https://www.cttpharmaceuticals.com/aurora-cannabis-makes-strategic-investment-in-ctt-pharmaceutical/2018-11-06T11:31:56-05:00https://www.cttpharmaceuticals.com/aurora-cannabis-inc-tseacb-makes-another-medical-based-cannabis-investment/2018-11-06T11:31:15-05:00https://www.cttpharmaceuticals.com/aurora-cannabis-makes-a-bigger-move-into-pharma-tech/2018-11-06T11:31:33-05:00https://www.cttpharmaceuticals.com/ctt-pharmaceuticals-announces-executive-management-change/2018-11-06T11:30:52-05:00https://www.cttpharmaceuticals.com/ctt-pharmaceuticals-appoints-aurora-nominee-dr-jason-dyck-to-board-of-directors/2018-11-06T11:28:31-05:00https://www.cttpharmaceuticals.com/aurora-cannabis-converts-ctt-pharmaceuticals-debenture-into-9-equity-position/2018-11-12T10:03:23-05:00https://www.cttpharmaceuticals.com/the-berkshire-hathaway-of-marijuana-stocks-is-smoking-hot-thanks-to-other-marijuana-stocks/2018-10-01T14:14:29-04:00https://www.cttpharmaceuticals.com/ctt-pharmaceutical-holdings-inc-ctth-announces-national-patent-applications-worldwide-for-orally-administrable-nanonized-opioids-cannabinoids-nutraceuticals-and-other-pharmaceutical-agents/2019-01-15T12:23:42-05:00https://www.cttpharmaceuticals.com/ctt-pharma-strengthens-board-and-management-team/2019-12-04T14:58:37-05:00https://www.cttpharmaceuticals.com/ctt-pharma-files-statement-of-claim-against-aurora-cannabis-and-appoints-dr-shane-morris-to-advisory-board/2020-08-27T09:46:32-04:00https://www.cttpharmaceuticals.com/ctt-enters-into-business-development-partnership-with-3-rivers-biotech/2020-09-08T11:46:42-04:00https://www.cttpharmaceuticals.com/ctt-pharmaceutical-corporate-update/2022-02-28T09:55:02-05:00https://www.cttpharmaceuticals.com/ctt-pharma-announces-ceo-and-new-corporate-strategy/2022-03-26T18:53:30-04:00https://www.cttpharmaceuticals.com/ctt-pharma-announces-south-africa-patent-approval/2022-03-26T18:53:23-04:00https://www.cttpharmaceuticals.com/ctt-pharma-announces-australia-patent-approval/2022-03-26T18:53:18-04:00https://www.cttpharmaceuticals.com/ctt-pharma-announces-mexico-patent-allowed/2022-04-15T17:03:42-04:00https://www.cttpharmaceuticals.com/ctt-pharma-signs-loi-with-black-rose-organics-a-canadian-licensed-producer/2022-04-15T17:04:31-04:00https://www.cttpharmaceuticals.com/ctt-pharma-update-on-european-patent/2022-04-15T17:05:07-04:00https://www.cttpharmaceuticals.com/ctt-pharma-strengthens-caffeine-patent-in-usa/2022-04-28T08:48:08-04:00https://www.cttpharmaceuticals.com/ctt-pharma-strengthens-vitamin-patent-in-usa/2022-04-28T08:48:52-04:00https://www.cttpharmaceuticals.com/ctt-pharma-files-trademark-names-pacific-blue-and-blue-rush/2022-06-09T09:33:21-04:00https://www.cttpharmaceuticals.com/ctt-pharma-announces-patent-granted-in-usa/2022-07-11T10:27:05-04:00https://www.cttpharmaceuticals.com/ctt-pharma-discusses-patent-coverage-for-pets/2022-07-11T10:27:53-04:00https://www.cttpharmaceuticals.com/ctt-pharma-announces-mexico-patent-officially-granted/2022-07-11T10:28:27-04:00https://www.cttpharmaceuticals.com/ctt-pharma-settles-lawsuit-with-aurora/2022-09-27T11:47:52-04:00https://www.cttpharmaceuticals.com/ctt-pharmas-ceo-issues-letter-to-shareholders/2022-10-05T10:34:51-04:00https://www.cttpharmaceuticals.com/ctt-pharma-will-utilize-patented-technology-for-additional-oral-products/2022-12-01T16:12:32-05:00https://www.cttpharmaceuticals.com/ctt-pharma-signs-agreement-for-new-oral-products/2022-12-01T16:12:10-05:00https://www.cttpharmaceuticals.com/ctt-pharma-starts-product-development/2022-12-01T16:13:15-05:00https://www.cttpharmaceuticals.com/ctt-pharma-updates-on-worldwide-patent-portfolio/2023-04-11T16:06:09-04:00https://www.cttpharmaceuticals.com/ctt-pharma-and-johns-hopkins-university-submits-proposal-for-15-millionnih-grant-for-smoking-cessation/2025-01-07T13:54:45-05:00